BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會

講師

懷特生技新藥(股)公司

 

Company Info

Name /PhytoHealth Corporation

Address /FL.5-1, NO.167, Fu Hsing North Road, Taipei 105, Taiwan, R.O.C

Website /www.phytohealth.com.tw

Presenter

Name /Angel Lee

Title /Vice Chairman/CEO

Email /angellee@maywufa.com.tw

Telephone /886-2-2545-3697 #2301

Fax /886-2-2514-0245

Mobile /

Company Type

Pharmaceutical

About the Company

PhytoHealth Corporation, a member of Maywufa Biopharma Group of companies, was incorporated in 1998 as a new drug development company with focus on research & development, repurposing & repositioning, manufacturing, marketing & sales of novel botanical drugs and chemically synthesized drugs.

The company has made significant progresses since its inception and received a number of major national awards and government grants in recognition of its achievements in both technological innovations and pharmaceutical product developments of botanical drugs.

「Oraphine Soft Capsules」developed by PhytoHealth Co.was approved by Ministry of Health and Welfare for market launching from 2020/7 .

「PG2 Lyo.Injection」was approved by the National Health Insurance Administration to obtain the health insurance benefits form 2021/3/1.

「PG2 Lyo.Injection」was approved by the National Health Insurance Administration to obtain the health insurance benefits form 2021/3/1.

Brief Description of main products or services

PHN012 PG2 Injection: is the 1st TFDA-approved Botanical New Drug in Taiwan for treating Cancer-Related Fatigue.

PHN131 Oraphine® (Oral nalbuphine) for treating Moderate to Severe Pain .

PHN013 PG2 Injection new indication for treating an orphan disease, idiopathic thrombocytopenic purpura (ITP).

PHN031 PH3 for preventing Osteoporosis.

PHN033 PH3 for treating Diabetic Nephropathy.

Contact Person

Name /Angel Lee

Email /angellee@maywufa.com.tw

Phone /886-2-2545-3697 # 2301